+13.1%
GSK vs PAYC
+46.2%
-33.1%
-22.4%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | PAYC | Excess | Alpha |
|---|---|---|---|---|
| 1D | +5.0% | +2.0% | +3.1% | +5.0% |
| 7D | +4.9% | +2.0% | +2.9% | +4.9% |
| 30D | +9.9% | +18.8% | -8.9% | +9.4% |
| 3M | +0.2% | +53.2% | -53.1% | -0.4% |
| 6M | +2.3% | +103.7% | -101.4% | +2.8% |
| YTD | +7.1% | +69.5% | -62.4% | +8.7% |
| 1Y | +13.1% | +48.8% | -35.7% | +15.7% |
| All | +13.1% | +46.2% | -33.1% | +15.7% |
Cumulative growth
Daily Returns
Daily percentage return beside PAYC.
Daily Out/Under-Performance
Portfolio return minus PAYC return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × PAYC return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded PAYC wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling